世界の遺伝子サイレンシング市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gene Silencing Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2514
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、遺伝子サイレンシングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（転写、転写後、減数分裂）、用途別市場規模（がん治療、神経疾患治療、傷跡治療、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・遺伝子サイレンシングの市場動向
・企業の競争状況、市場シェア
・遺伝子サイレンシングの種類別市場規模（転写、転写後、減数分裂）
・遺伝子サイレンシングの用途別市場規模（がん治療、神経疾患治療、傷跡治療、その他）
・遺伝子サイレンシングの北米市場規模2016-2027（アメリカ、カナダ）
・遺伝子サイレンシングのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・遺伝子サイレンシングのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・遺伝子サイレンシングの中南米市場規模2016-2027（メキシコ、ブラジル）
・遺伝子サイレンシングの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Alnylam Pharmaceuticals、Benitec Biopharma、Arrowhead Pharmaceuticals、Merck Group、Eli Lilly (Dicerna Pharmaceuticals)、Monsanto (Bayer AG)、RXi Pharmaceuticals、Silence Therapeutics plc、Idera Pharmaceuticals）
・結論

Gene silencing is the regulation of gene expression in a cell to prevent the expression of a certain gene. Gene silencing can occur during either transcription or translation and is often used in research.In particular, methods used to silence genes are being increasingly used to produce therapeutics to combat cancer and diseases, such as infectious diseases and neurodegenerative disorders.

Market Analysis and Insights: Global Gene Silencing Market
The global Gene Silencing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Silencing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Silencing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Silencing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Silencing market.

Global Gene Silencing Scope and Market Size
Gene Silencing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Silencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Transcriptional
Post-transcriptional
Meiotic

Segment by Application
Cancer Treatment
Neurological Diseases Treatment
Scar Treatment
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Alnylam Pharmaceuticals
Benitec Biopharma
Arrowhead Pharmaceuticals
Merck Group
Eli Lilly (Dicerna Pharmaceuticals)
Monsanto (Bayer AG)
RXi Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Silencing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Transcriptional
1.2.3 Post-transcriptional
1.2.4 Meiotic
1.3 Market by Application
1.3.1 Global Gene Silencing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer Treatment
1.3.3 Neurological Diseases Treatment
1.3.4 Scar Treatment
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gene Silencing Market Perspective (2016-2027)
2.2 Gene Silencing Growth Trends by Regions
2.2.1 Gene Silencing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Silencing Historic Market Share by Regions (2016-2021)
2.2.3 Gene Silencing Forecasted Market Size by Regions (2022-2027)
2.3 Gene Silencing Industry Dynamic
2.3.1 Gene Silencing Market Trends
2.3.2 Gene Silencing Market Drivers
2.3.3 Gene Silencing Market Challenges
2.3.4 Gene Silencing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gene Silencing Players by Revenue
3.1.1 Global Top Gene Silencing Players by Revenue (2016-2021)
3.1.2 Global Gene Silencing Revenue Market Share by Players (2016-2021)
3.2 Global Gene Silencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Silencing Revenue
3.4 Global Gene Silencing Market Concentration Ratio
3.4.1 Global Gene Silencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Silencing Revenue in 2020
3.5 Gene Silencing Key Players Head office and Area Served
3.6 Key Players Gene Silencing Product Solution and Service
3.7 Date of Enter into Gene Silencing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Silencing Breakdown Data by Type
4.1 Global Gene Silencing Historic Market Size by Type (2016-2021)
4.2 Global Gene Silencing Forecasted Market Size by Type (2022-2027)

5 Gene Silencing Breakdown Data by Application
5.1 Global Gene Silencing Historic Market Size by Application (2016-2021)
5.2 Global Gene Silencing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gene Silencing Market Size (2016-2027)
6.2 North America Gene Silencing Market Size by Type
6.2.1 North America Gene Silencing Market Size by Type (2016-2021)
6.2.2 North America Gene Silencing Market Size by Type (2022-2027)
6.2.3 North America Gene Silencing Market Size by Type (2016-2027)
6.3 North America Gene Silencing Market Size by Application
6.3.1 North America Gene Silencing Market Size by Application (2016-2021)
6.3.2 North America Gene Silencing Market Size by Application (2022-2027)
6.3.3 North America Gene Silencing Market Size by Application (2016-2027)
6.4 North America Gene Silencing Market Size by Country
6.4.1 North America Gene Silencing Market Size by Country (2016-2021)
6.4.2 North America Gene Silencing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Gene Silencing Market Size (2016-2027)
7.2 Europe Gene Silencing Market Size by Type
7.2.1 Europe Gene Silencing Market Size by Type (2016-2021)
7.2.2 Europe Gene Silencing Market Size by Type (2022-2027)
7.2.3 Europe Gene Silencing Market Size by Type (2016-2027)
7.3 Europe Gene Silencing Market Size by Application
7.3.1 Europe Gene Silencing Market Size by Application (2016-2021)
7.3.2 Europe Gene Silencing Market Size by Application (2022-2027)
7.3.3 Europe Gene Silencing Market Size by Application (2016-2027)
7.4 Europe Gene Silencing Market Size by Country
7.4.1 Europe Gene Silencing Market Size by Country (2016-2021)
7.4.2 Europe Gene Silencing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gene Silencing Market Size (2016-2027)
8.2 Asia-Pacific Gene Silencing Market Size by Type
8.2.1 Asia-Pacific Gene Silencing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Silencing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Silencing Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Silencing Market Size by Application
8.3.1 Asia-Pacific Gene Silencing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Silencing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Silencing Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Silencing Market Size by Region
8.4.1 Asia-Pacific Gene Silencing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Silencing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gene Silencing Market Size (2016-2027)
9.2 Latin America Gene Silencing Market Size by Type
9.2.1 Latin America Gene Silencing Market Size by Type (2016-2021)
9.2.2 Latin America Gene Silencing Market Size by Type (2022-2027)
9.2.3 Latin America Gene Silencing Market Size by Type (2016-2027)
9.3 Latin America Gene Silencing Market Size by Application
9.3.1 Latin America Gene Silencing Market Size by Application (2016-2021)
9.3.2 Latin America Gene Silencing Market Size by Application (2022-2027)
9.3.3 Latin America Gene Silencing Market Size by Application (2016-2027)
9.4 Latin America Gene Silencing Market Size by Country
9.4.1 Latin America Gene Silencing Market Size by Country (2016-2021)
9.4.2 Latin America Gene Silencing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gene Silencing Market Size (2016-2027)
10.2 Middle East & Africa Gene Silencing Market Size by Type
10.2.1 Middle East & Africa Gene Silencing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Silencing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Silencing Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Silencing Market Size by Application
10.3.1 Middle East & Africa Gene Silencing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Silencing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Silencing Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Silencing Market Size by Country
10.4.1 Middle East & Africa Gene Silencing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Silencing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Details
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals Gene Silencing Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in Gene Silencing Business (2016-2021)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Benitec Biopharma
11.2.1 Benitec Biopharma Company Details
11.2.2 Benitec Biopharma Business Overview
11.2.3 Benitec Biopharma Gene Silencing Introduction
11.2.4 Benitec Biopharma Revenue in Gene Silencing Business (2016-2021)
11.2.5 Benitec Biopharma Recent Development
11.3 Arrowhead Pharmaceuticals
11.3.1 Arrowhead Pharmaceuticals Company Details
11.3.2 Arrowhead Pharmaceuticals Business Overview
11.3.3 Arrowhead Pharmaceuticals Gene Silencing Introduction
11.3.4 Arrowhead Pharmaceuticals Revenue in Gene Silencing Business (2016-2021)
11.3.5 Arrowhead Pharmaceuticals Recent Development
11.4 Merck Group
11.4.1 Merck Group Company Details
11.4.2 Merck Group Business Overview
11.4.3 Merck Group Gene Silencing Introduction
11.4.4 Merck Group Revenue in Gene Silencing Business (2016-2021)
11.4.5 Merck Group Recent Development
11.5 Eli Lilly (Dicerna Pharmaceuticals)
11.5.1 Eli Lilly (Dicerna Pharmaceuticals) Company Details
11.5.2 Eli Lilly (Dicerna Pharmaceuticals) Business Overview
11.5.3 Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Introduction
11.5.4 Eli Lilly (Dicerna Pharmaceuticals) Revenue in Gene Silencing Business (2016-2021)
11.5.5 Eli Lilly (Dicerna Pharmaceuticals) Recent Development
11.6 Monsanto (Bayer AG)
11.6.1 Monsanto (Bayer AG) Company Details
11.6.2 Monsanto (Bayer AG) Business Overview
11.6.3 Monsanto (Bayer AG) Gene Silencing Introduction
11.6.4 Monsanto (Bayer AG) Revenue in Gene Silencing Business (2016-2021)
11.6.5 Monsanto (Bayer AG) Recent Development
11.7 RXi Pharmaceuticals
11.7.1 RXi Pharmaceuticals Company Details
11.7.2 RXi Pharmaceuticals Business Overview
11.7.3 RXi Pharmaceuticals Gene Silencing Introduction
11.7.4 RXi Pharmaceuticals Revenue in Gene Silencing Business (2016-2021)
11.7.5 RXi Pharmaceuticals Recent Development
11.8 Silence Therapeutics plc
11.8.1 Silence Therapeutics plc Company Details
11.8.2 Silence Therapeutics plc Business Overview
11.8.3 Silence Therapeutics plc Gene Silencing Introduction
11.8.4 Silence Therapeutics plc Revenue in Gene Silencing Business (2016-2021)
11.8.5 Silence Therapeutics plc Recent Development
11.9 Idera Pharmaceuticals
11.9.1 Idera Pharmaceuticals Company Details
11.9.2 Idera Pharmaceuticals Business Overview
11.9.3 Idera Pharmaceuticals Gene Silencing Introduction
11.9.4 Idera Pharmaceuticals Revenue in Gene Silencing Business (2016-2021)
11.9.5 Idera Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gene Silencing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Transcriptional
Table 3. Key Players of Post-transcriptional
Table 4. Key Players of Meiotic
Table 5. Global Gene Silencing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gene Silencing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gene Silencing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Gene Silencing Market Share by Regions (2016-2021)
Table 9. Global Gene Silencing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Gene Silencing Market Share by Regions (2022-2027)
Table 11. Gene Silencing Market Trends
Table 12. Gene Silencing Market Drivers
Table 13. Gene Silencing Market Challenges
Table 14. Gene Silencing Market Restraints
Table 15. Global Gene Silencing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Gene Silencing Market Share by Players (2016-2021)
Table 17. Global Top Gene Silencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Silencing as of 2020)
Table 18. Ranking of Global Top Gene Silencing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Gene Silencing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gene Silencing Product Solution and Service
Table 22. Date of Enter into Gene Silencing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Silencing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Gene Silencing Revenue Market Share by Type (2016-2021)
Table 26. Global Gene Silencing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Gene Silencing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Gene Silencing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Gene Silencing Revenue Market Share by Application (2016-2021)
Table 30. Global Gene Silencing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Gene Silencing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Gene Silencing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Gene Silencing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Gene Silencing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Gene Silencing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Gene Silencing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Gene Silencing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Gene Silencing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Gene Silencing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Gene Silencing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Gene Silencing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Gene Silencing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Gene Silencing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Gene Silencing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Gene Silencing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gene Silencing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gene Silencing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gene Silencing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Gene Silencing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Gene Silencing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Gene Silencing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Gene Silencing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Gene Silencing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Gene Silencing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Gene Silencing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Gene Silencing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Gene Silencing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gene Silencing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gene Silencing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gene Silencing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Gene Silencing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Alnylam Pharmaceuticals Company Details
Table 63. Alnylam Pharmaceuticals Business Overview
Table 64. Alnylam Pharmaceuticals Gene Silencing Product
Table 65. Alnylam Pharmaceuticals Revenue in Gene Silencing Business (2016-2021) & (US$ Million)
Table 66. Alnylam Pharmaceuticals Recent Development
Table 67. Benitec Biopharma Company Details
Table 68. Benitec Biopharma Business Overview
Table 69. Benitec Biopharma Gene Silencing Product
Table 70. Benitec Biopharma Revenue in Gene Silencing Business (2016-2021) & (US$ Million)
Table 71. Benitec Biopharma Recent Development
Table 72. Arrowhead Pharmaceuticals Company Details
Table 73. Arrowhead Pharmaceuticals Business Overview
Table 74. Arrowhead Pharmaceuticals Gene Silencing Product
Table 75. Arrowhead Pharmaceuticals Revenue in Gene Silencing Business (2016-2021) & (US$ Million)
Table 76. Arrowhead Pharmaceuticals Recent Development
Table 77. Merck Group Company Details
Table 78. Merck Group Business Overview
Table 79. Merck Group Gene Silencing Product
Table 80. Merck Group Revenue in Gene Silencing Business (2016-2021) & (US$ Million)
Table 81. Merck Group Recent Development
Table 82. Eli Lilly (Dicerna Pharmaceuticals) Company Details
Table 83. Eli Lilly (Dicerna Pharmaceuticals) Business Overview
Table 84. Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Product
Table 85. Eli Lilly (Dicerna Pharmaceuticals) Revenue in Gene Silencing Business (2016-2021) & (US$ Million)
Table 86. Eli Lilly (Dicerna Pharmaceuticals) Recent Development
Table 87. Monsanto (Bayer AG) Company Details
Table 88. Monsanto (Bayer AG) Business Overview
Table 89. Monsanto (Bayer AG) Gene Silencing Product
Table 90. Monsanto (Bayer AG) Revenue in Gene Silencing Business (2016-2021) & (US$ Million)
Table 91. Monsanto (Bayer AG) Recent Development
Table 92. RXi Pharmaceuticals Company Details
Table 93. RXi Pharmaceuticals Business Overview
Table 94. RXi Pharmaceuticals Gene Silencing Product
Table 95. RXi Pharmaceuticals Revenue in Gene Silencing Business (2016-2021) & (US$ Million)
Table 96. RXi Pharmaceuticals Recent Development
Table 97. Silence Therapeutics plc Company Details
Table 98. Silence Therapeutics plc Business Overview
Table 99. Silence Therapeutics plc Revenue in Gene Silencing Business (2016-2021) & (US$ Million)
Table 100. Silence Therapeutics plc Recent Development
Table 101. Idera Pharmaceuticals Company Details
Table 102. Idera Pharmaceuticals Business Overview
Table 103. Idera Pharmaceuticals Gene Silencing Product
Table 104. Idera Pharmaceuticals Revenue in Gene Silencing Business (2016-2021) & (US$ Million)
Table 105. Idera Pharmaceuticals Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Silencing Market Share by Type: 2020 VS 2027
Figure 2. Transcriptional Features
Figure 3. Post-transcriptional Features
Figure 4. Meiotic Features
Figure 5. Global Gene Silencing Market Share by Application: 2020 VS 2027
Figure 6. Cancer Treatment Case Studies
Figure 7. Neurological Diseases Treatment Case Studies
Figure 8. Scar Treatment Case Studies
Figure 9. Other Case Studies
Figure 10. Gene Silencing Report Years Considered
Figure 11. Global Gene Silencing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Gene Silencing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Gene Silencing Market Share by Regions: 2020 VS 2027
Figure 14. Global Gene Silencing Market Share by Regions (2022-2027)
Figure 15. Global Gene Silencing Market Share by Players in 2020
Figure 16. Global Top Gene Silencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Silencing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Gene Silencing Revenue in 2020
Figure 18. Global Gene Silencing Revenue Market Share by Type (2016-2021)
Figure 19. Global Gene Silencing Revenue Market Share by Type (2022-2027)
Figure 20. North America Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Gene Silencing Market Share by Type (2016-2027)
Figure 22. North America Gene Silencing Market Share by Application (2016-2027)
Figure 23. North America Gene Silencing Market Share by Country (2016-2027)
Figure 24. United States Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Gene Silencing Market Share by Type (2016-2027)
Figure 28. Europe Gene Silencing Market Share by Application (2016-2027)
Figure 29. Europe Gene Silencing Market Share by Country (2016-2027)
Figure 30. Germany Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Gene Silencing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Gene Silencing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Gene Silencing Market Share by Region (2016-2027)
Figure 40. China Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Gene Silencing Market Share by Type (2016-2027)
Figure 48. Latin America Gene Silencing Market Share by Application (2016-2027)
Figure 49. Latin America Gene Silencing Market Share by Country (2016-2027)
Figure 50. Mexico Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Gene Silencing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Gene Silencing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Gene Silencing Market Share by Country (2016-2027)
Figure 56. Turkey Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Gene Silencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2016-2021)
Figure 60. Benitec Biopharma Revenue Growth Rate in Gene Silencing Business (2016-2021)
Figure 61. Arrowhead Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2016-2021)
Figure 62. Merck Group Revenue Growth Rate in Gene Silencing Business (2016-2021)
Figure 63. Eli Lilly (Dicerna Pharmaceuticals) Revenue Growth Rate in Gene Silencing Business (2016-2021)
Figure 64. Monsanto (Bayer AG) Revenue Growth Rate in Gene Silencing Business (2016-2021)
Figure 65. RXi Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2016-2021)
Figure 66. Silence Therapeutics plc Revenue Growth Rate in Gene Silencing Business (2016-2021)
Figure 67. Idera Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界のがん遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Cancer Gene Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1066 2021年4月 99Pages
QYResearch社発行の本調査資料では、がん遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍溶解性ウイルス療法、遺伝子導入、遺伝子誘導免疫療法）、用途別市場規模（病院、診断センター、研究機関）、主要地域別市場規模（北米、アメリ...

世界の遺伝子治療薬市場規模・現状・予測（2021年-2027年）

Global Drugs Based on Gene Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1998 2021年4月 93Pages
QYResearch社発行の本調査資料では、遺伝子治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ウイルス用、非ウイルス用）、用途別市場規模（神経疾患、がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓...

世界のムコ多糖症遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Mucopolysaccharidosis Market Size, Status and Forecast 2021-2027
QYR2104Z2520 2021年4月 92Pages
QYResearch社発行の本調査資料では、ムコ多糖症遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、ICV、脳内、大槽内）、用途別市場規模（ムコ多糖症I型、ムコ多糖症II型、ムコ多糖症III型A型、ムコ多糖症型III型B型）...

世界のDNA遺伝子チップ市場規模・現状・予測（2021年-2027年）

Global DNA Gene Chip Market Size, Status and Forecast 2021-2027
QYR2104Z1940 2021年4月 94Pages
QYResearch社発行の本調査資料では、DNA遺伝子チップのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CDNA（相補DNA）、ODNA（オリゴヌクレオチドDNA））、用途別市場規模（遺伝子発現、がん診断・治療、創薬、遺伝、その他）、主要...

世界の遺伝子発現市場規模・現状・予測（2021年-2027年）

Global Gene Expression Market Size, Status and Forecast 2021-2027
QYR2104Z2512 2021年4月 98Pages
QYResearch社発行の本調査資料では、遺伝子発現のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消耗品、機器）、用途別市場規模（創薬、診断）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中...

世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Ovarian Cancer Market Size, Status and Forecast 2021-2027
QYR2104Z2521 2021年4月 99Pages
QYResearch社発行の本調査資料では、卵巣がん遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、腫瘍内、腹腔内）、用途別市場規模（卵巣がん（詳細不明）、再発卵巣上皮がん、プラチナ耐性卵巣がん）、主要地域別市場規模（北米、ア...

世界の加齢性黄斑変性症向け遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Age-related Macular Degeneration Market Size, Status and Forecast 2021-2027
QYR2104Z2517 2021年4月 97Pages
QYResearch社発行の本調査資料では、加齢性黄斑変性症向け遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（網膜下、硝子体内）、用途別市場規模（単剤療法、併用療法）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界のFAM20B遺伝子（XYLK抗体）市場規模・現状・予測（2021年-2027年）

Global FAM20B Gene(XYLK Antibody) Market Size, Status and Forecast 2021-2027
QYR2104Z2313 2021年4月 92Pages
QYResearch社発行の本調査資料では、FAM20B遺伝子（XYLK抗体）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（90％以上、95％以上、99％以上、その他）、用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他）、主要地...

世界の遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z2522 2021年4月 98Pages
QYResearch社発行の本調査資料では、遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（Ex vivo、In Vivo）、用途別市場規模（がん、単発性、感染症、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界の遺伝子合成市場規模・現状・予測（2021年-2027年）

Global Gene Synthesis Market Size, Status and Forecast 2021-2027
QYR2104Z2515 2021年4月 92Pages
QYResearch社発行の本調査資料では、遺伝子合成のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（1000 bp以下、1001〜3000 bp、3001〜5000 bp、5000bp以上）、用途別市場規模（商業用、学術研究）、主要地域別市場...

世界のがん遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression. Market Analysis and Insights: Global Gene Therapy For Cancer Market The global Gene Therapy For Cancer market size is projected to …
世界のがん遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression. Market Analysis and Insights: Global Gene Therapy For Cancer Market The global Gene Therapy For Cancer market size is projected to …
世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
世界のがん遺伝子治療市場規模・現状・予測（2021年-2027年） Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has be…
世界のDNA遺伝子チップ市場規模・現状・予測（2021年-2027年） DNA gene chips or DNA microarrays are tiny chips that are engrafted with DNA molecules. A DNA gene chip size resembles the size of a postage stamp. A DNA microarray consists of a set of microscopic DNA spots attached on a solid surface. Every DNA spot consists of picomoles of a definite DNA sequence…